Geneva Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-662,825
Closed -$16.1M 130
2024
Q4
$16.1M Sell
662,825
-32,590
-5% -$931K 0.28% 84
2024
Q3
$25.8M Buy
695,415
+2,241
+0.3% +$83.6K 0.43% 73
2024
Q2
$33M Sell
693,174
-18,020
-3% -$790K 0.6% 53
2024
Q1
$27.2M Sell
711,194
-206,962
-23% -$6.73M 0.48% 69
2023
Q4
$28.7M Sell
918,156
-35,822
-4% -$1.29M 0.54% 64
2023
Q3
$38.3M Buy
953,978
+2,949
+0.3% +$138K 0.81% 45
2023
Q2
$50M Sell
951,029
-6,828
-0.7% -$416K 0.99% 38
2023
Q1
$61.3M Buy
957,857
+17,400
+2% +$1.14M 1.25% 29
2022
Q4
$45.6M Sell
940,457
-6,669
-0.7% -$418K 1.03% 37
2022
Q3
$66.8M Buy
947,126
+38,327
+4% +$3.28M 1.54% 17
2022
Q2
$64.5M Sell
908,799
-1,078
-0.1% -$69.5K 1.48% 19
2022
Q1
$72.7M Buy
909,877
+158,452
+21% +$11.8M 1.4% 24
2021
Q4
$68.6M Buy
751,425
+55,405
+8% +$5.94M 1.11% 33
2021
Q3
$89.5M Sell
696,020
-125,697
-15% -$17.6M 1.52% 19
2021
Q2
$125M Sell
821,717
-113,249
-12% -$14.9M 2.04% 6
2021
Q1
$98.6M Sell
934,966
-348,267
-27% -$34.9M 1.68% 15
2020
Q4
$102M Sell
1,283,233
-66,878
-5% -$4.89M 1.72% 14
2020
Q3
$76.4M Buy
1,350,111
+31,581
+2% +$1.7M 1.58% 15
2020
Q2
$81.1M Buy
1,318,530
+36,728
+3% +$1.5M 1.76% 11
2020
Q1
$41.4M Buy
+1,281,802
New +$43.2M 1.18% 29

Other funds holding STAA